Jade Biosciences revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JBIO annual revenue was $0.0, with N/A growth year-over-year.
JBIO revenue history
Current Revenue
$0.0
Current Earnings
-$49.0M
Current Profit Margin
0%
Be the first to know when JBIO announces revenue.
JBIO Revenue History By Year
JBIO Yearly Revenue
JBIO Revenue
JBIO Change
JBIO Revenue Growth
2024-12-31
$0.00
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
2019-12-31
$0.00
N/A
N/A
1 of 1
Jade Biosciences Revenue FAQ
What was JBIO's revenue last quarter?
Jade Biosciences (NASDAQ: JBIO) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Jade Biosciences's revenue was $0.00.
What was Jade Biosciences's revenue in 2024?
Jade Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Jade Biosciences make in a day?
Based on Jade Biosciences annual revenue for the past five years, JBIO makes an average of $0.00 per day.
What was Jade Biosciences's annual revenue growth in the past year?
As of Q2 2025, Jade Biosciences's revenue has grown null year over year. Jade Biosciences's revenue in the past year totaled $0.00.
How much does Jade Biosciences make in a year?
Jade Biosciences's revenue by year for the past five years is:
Jade Biosciences's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Jade Biosciences's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Jade Biosciences's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Jade Biosciences's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Jade Biosciences's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.